Steven C. Quay

Insider Reports History

Location
Bothell, WA
Signature
/s/ Steven C. Quay
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven C. Quay:

Company Role Class Num Shares Value Price $ Report Date Ownership
ATOSSA THERAPEUTICS, INC. President & CEO, Director Stock Options (right to buy) 950,000 $572,850 $0.6030 20 Jan 2026 Direct
ATOSSA THERAPEUTICS, INC. President & CEO, Director Common Stock 339,101 $200,069 $0.5900 20 Jan 2026 Direct
ATOSSA THERAPEUTICS, INC. President & CEO, Director Common Stock 22,254 $13,129 $0.5900 20 Jan 2026 By Ensisheim Partners, LLC
ATOSSA THERAPEUTICS, INC. President & CEO, Director Stock Option (right to buy) 1,366,062 15 May 2025 Direct

Insider Reports Filed by Steven C. Quay

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATOS ATOSSA THERAPEUTICS, INC. 20 Jan 2026 2 +$572,850 4 President & CEO, Director 22 Jan 2026, 14:11
ATOS ATOSSA THERAPEUTICS, INC. 21 May 2025 1 +$9,887 4 President & CEO, Director 22 May 2025, 18:27
ATOS ATOSSA THERAPEUTICS, INC. 15 May 2025 1 $0 4 President & CEO, Director 16 May 2025, 16:05
ATOS ATOSSA THERAPEUTICS, INC. 27 Jun 2024 1 $0 4 President & CEO, Director 01 Jul 2024, 16:00
ATOS ATOSSA THERAPEUTICS, INC. 02 Mar 2023 1 $0 4 President & CEO, Director 06 Mar 2023, 15:11
ATOS ATOSSA THERAPEUTICS, INC. 24 Feb 2022 1 $0 4 President & CEO, Director 28 Feb 2022, 16:15
ATOS ATOSSA THERAPEUTICS, INC. 14 May 2021 1 $0 4 President & CEO, Director 18 May 2021, 16:18
ATOS ATOSSA THERAPEUTICS, INC. 14 May 2021 1 $0 4 President & CEO, Director 18 May 2021, 16:18